Sign in →

Test Code LH LUTEINIZING HORMONE, SERUM

Additional Codes

Software Test Code
Label Text                               LH
EPIC LAB87                               

Performing Laboratory

NorDx Laboratories

Useful For

Assessing the function of the male and female reproductive systems including the prediction of ovulation and evaluation of infertility, diagnosis of pituitary disorders, and the diagnosis of suspected hypogonadism

Method Name

Electrochemiluminescent Immunoassay (ECLIA)

Reference Values

Males: 1.7 - 8.6 mlU/mL

 

Females:

Follicular phase: 2.4 - 12.6 mlU/mL

Mid Cycle: 14.0 - 95.6 mlU/mL

Luteal phase: 1.0 - 11.4 mlU/mL

Postmenopausal: 7.7 - 58.5 mlU/mL

Days and Times Test Performed

Monday through Sunday

Report Available

1 Day

Available Stat

Specimen Type

Serum

Preferred Container

Serum Separator Tube (SST)

Preferred Volume

Serum: 1 mL (Serum Separator Tube (SST))

Minimum Volume

Serum: 0.5 mL (Serum Separator Tube (SST))

Specimen Collection and Handling

1. Spin specimen, separated from clot and send refrigerated.

2. Sample should not be collected on patients receiving therapy with high biotin doses (i.e. >5 mg/day) until at least 8 hours after the last biotin administration.

Specimen Stability Information

Specimen Type: Serum

Frozen: 3 Months

Refrigerated: 7 Days

Must be spun/separated within: 2 Hours

Add On Capable

Yes

Advance Beneficiary Notice Requirements

No ABN Required

CPT Code Information

CPT Code

CPT Description

CPT Disclaimer

83002 Gonadotropin, Luteinizing Hormone (LH), Quantitative  

Keywords

ADENOMA, PITUITARY

INTERSTITIAL CELL STIMULATING HORMONE

LH (LUTEINIZING HORMONE)

LUTEINIZING HORMONE (LH)

PITUITARY ADENOMA

PITUITARY BATTERY

PITUITARY GONADOTROPINS

Performing Laboratory Location

NorDx Laboratories

Clinical Significance

No sample should be collected on patients receiving therapy with high biotin doses(i.e. biotin therapy for Multiple Sclerosis or oncology patients; skin, hair and nail supplements, or multivitamins containing > 5 mg/day) until at least 12 hours after the last biotin administration. If unsure, or if the clinical picture does not fit the results please contact the laboratory. We have methods to check for biotin interference as well as for any other interferences and for the accuracy of the results.

Biotin interference would falsely decrease the result of this assay.

LOINC Code Information

10501-5

Acceptable Alternative Container(s)

Plasma Separator Tube (PST)

Red Top Tube